Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Plos Pathogens|March 25, 2021
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster modelDrishya Kurup, Delphine C Malherbe, Christoph Wirblich, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Journal of Virology|May 30, 2006
The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopesAlexander Bukreyev, Maria Elina Serra, Federico R Laham, et al.
Journal of Virology|August 24, 2018
Phosphorylated VP30 of Marburg Virus Is a Repressor of TranscriptionBersabeh Tigabu, Palaniappan Ramanathan, Andrey Ivanov, et al.
Assay and Drug Development Technologies|February 25, 2015
Adapting high-throughput screening methods and assays for biocontainment laboratoriesLynn Rasmussen, Bersabeh Tigabu, E Lucile White, et al.
Mbio|October 11, 2018
Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA SynthesisJingru Fang, Colette Pietzsch, Palaniappan Ramanathan, et al.
The Journal of Infectious Diseases|July 20, 2023
A Single-Dose Intranasal Combination Panebolavirus VaccineDelphine C Malherbe, J Brian Kimble, Caroline Atyeo, et al.
Journal of Virology|February 14, 2006
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challengeAlexander Bukreyev, Lijuan Yang, Sherif R Zaki, et al.
Assay and Drug Development Technologies|April 17, 2014
A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virusBersabeh Tigabu, Lynn Rasmussen, E Lucile White, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Plos Pathogens|March 25, 2021
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster modelDrishya Kurup, Delphine C Malherbe, Christoph Wirblich, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Journal of Virology|May 30, 2006
The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopesAlexander Bukreyev, Maria Elina Serra, Federico R Laham, et al.
Journal of Virology|August 24, 2018
Phosphorylated VP30 of Marburg Virus Is a Repressor of TranscriptionBersabeh Tigabu, Palaniappan Ramanathan, Andrey Ivanov, et al.
Assay and Drug Development Technologies|February 25, 2015
Adapting high-throughput screening methods and assays for biocontainment laboratoriesLynn Rasmussen, Bersabeh Tigabu, E Lucile White, et al.
Mbio|October 11, 2018
Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA SynthesisJingru Fang, Colette Pietzsch, Palaniappan Ramanathan, et al.
The Journal of Infectious Diseases|July 20, 2023
A Single-Dose Intranasal Combination Panebolavirus VaccineDelphine C Malherbe, J Brian Kimble, Caroline Atyeo, et al.
Journal of Virology|February 14, 2006
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challengeAlexander Bukreyev, Lijuan Yang, Sherif R Zaki, et al.
Assay and Drug Development Technologies|April 17, 2014
A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virusBersabeh Tigabu, Lynn Rasmussen, E Lucile White, et al.
Pageof 17